Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >
Sphere Fluidics expands into additional facility
Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Read More

TTP Labtech introduces chameleon
TTP Labtech introduces chameleon, automated system for next generation cryo-electron microscopy sample-prep

Read More

The Native Antigen Company Introduces Rubella Virus-Like Particles
The Native Antigen Company, one of the world’s leading suppliers of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases, today announced the release of its Rubella virus-like particles (VLPs) at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, CA, USA.

Read More

WuXi Xpress White Paper: RNA therapeutics to become a dominant treatment modality within a decade
Industry experts speaking within a newly released WuXi Xpress White Paper on RNA have identified 2019 as potentially a key turning point for the modality, sparking the beginnings of a new era for RNA therapeutics.

Read More

NemaMetrix raises $5 million USD funding and strengthens senior team
NemaMetrix, an Oregon-based company that provides phenotyping and functional analysis using C. elegans nematodes, today announced it has closed a $5 million USD funding round to expand its Precisome platform: a tool for in vivo testing for early drug discovery, agribio, and precision medicine.

Read More

IONTAS announces new antibody optimisation agreement with Teva Pharmaceuticals
IONTAS Limited (IONTAS), a leader in antibody discovery and optimisation of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimisation of human antibodies for use as biotherapeutics.

Read More

BIA selected for manufacturing process development support
BIA Separations selected for manufacturing process development support for gene therapy pipeline.

Read More

Arcis and Mirnax Biosens sign exclusive license agreement for Arcis sample prep technology
Enables stabilisation of microRNA biomarkers for early disease diagnosis.

Read More

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director
Board appointment will help guide target identification and drug discovery.

Read More

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications

Read More

Expedeon introduces Lightning-Link Metal Labeling Kits for single cell analysis
Novel antibody labeling immunoassay technology for multiplex immune profiling addresses one of the fastest growing, billion-dollar life science market sectors

Read More

Next-Gen. Open Air Orbital Shakers Set New Standards for Reliability and Innovation
The Thermo Scientific Solaris Orbital Shakers provide dependable performance and simplified operation in a compact benchtop design

Read More

Owlstone Announces Novel Approach to Breath-Based Testing
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease

Read More

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics

Read More

Vernalis and PhoreMost announce drug discovery collaboration
Ligand subsidiary Vernalis and PhoreMost Limited announce drug discovery collaboration for novel oncology target.

Read More

Avacta Group plc hits clinical candidate selection milestone for Affimer PD-L1 inhibitor
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces that it has selected the clinical development candidate for first-time-in-human clinical trials of the Affimer platform.

Read More

Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >